Mark Krogh Hvistendahl (Mark K Hvistendahl)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Replacement Therapy

Cystic Fibrosis

Top Venues

JPEN. Journal of parenteral and enteral nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Rahim Mohammad Naimi, Mark Krogh Hvistendahl, Steen S Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj A Nerup, Rikard Ambrus, Michael P Achiam, Lars B Svendsen, Palle Bekker Jeppesen
Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial. JPEN. Journal of parenteral and enteral nutrition (2022)
Mark Krogh Hvistendahl, Rahim Mohammad Naimi, Svend Høime Hansen, Jens Frederik Rehfeld, Hannelouise Kissow, Jens Pedersen, Lars Ove Dragsted, David Peick Sonne, Filip Krag Knop, Palle Bekker Jeppesen
Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial. JPEN. Journal of parenteral and enteral nutrition (2021)
Mark Krogh Hvistendahl, Rahim Mohammad Naimi, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Palle Bekker Jeppesen
Effect of Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial. JPEN. Journal of parenteral and enteral nutrition 44 (8) (2020)